31 Mar 2021
Assets9.48
Total Income16.95
Profit After Tax0.17
NET Worth0.29
Reserves and Surplus0.28
Total Borrowing2.32
Open 7th Nov 2023 · Close 9th Nov 2023 · Listing 20th Nov 2023
Sunrest Lifescience is a SME IPO with an issue size of ₹10.85 crore, proposed for listing on NSE SME. The offer opens on 7th Nov 2023 and closes on 9th Nov 2023. The issue structure includes a fresh issue of ₹10.30 crore.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 1600 | — |
| Object | Amount |
|---|---|
| Meeting Working Capital Requirements | ₹8.55 Cr |
| General Corporate Purpose | ₹1.40 Cr |
| KPI |
|---|
| ROE |
| ROCE |
| Debt / Equity |
| RoNW |
| PAT Margin |
| Expense | Amount |
|---|---|
| Fees payable to the Lead Manager (including underwriting commission) | ₹0.30 Cr |
| Brokerage, selling commission and upload fees | ₹0.12 Cr |
| Fees payable to the Legal Advisors to the Issue | ₹0.03 Cr |
| Fees to the Registrar to the Issue | ₹0.03 Cr |
| Fees payable to the Regulators including stock exchanges | ₹0.07 Cr |
| Printing and distribution of Issue stationary | ₹0.05 Cr |
| Advertising and Marketing Expenses | ₹0.25 Cr |
| Processing fees to SCSBs for ASBA Applications procured by the members of the Syndicate or Registered Brokers and submitted with the SCSBs | ₹0.01 Cr |
| Processing fees to Issuer banks for UPI Mechanism w.r.t application Forms procured by the members of the Syndicate, Registered Brokers, RTAs or the CDPs and submitted to them | ₹0.01 Cr |
| Others (bankers to the Issue, auditor’s fees etc.) | ₹0.03 Cr |